Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2025-12-24 @ 7:19 PM
NCT ID:
NCT04996303
Eligibility Criteria:
Inclusion Criteria:
* Among patients with clinically or histologically confirmed idiopathic pulmonary fibrosis, patients who visited the emergency room with dyspnea symptoms
* Patients within 1 month of exacerbation of respiratory symptoms
* Patients with increased GGO or worsening of IPF on chest CT within the last 2 weeks
* Patients who understand the purpose of the clinical study and voluntarily agree to participate in this clinical study
* When it is determined that steroid administration is necessary under the judgment of the medical staff during the treatment process
Exclusion Criteria:
* Patients who complain of dyspnea symptoms due to causes other than the respiratory system, such as fluid overload, congestive heart failure, pulmonary embolism, etc.
* Patients whose respiratory symptoms have worsened for more than 1 month
* Persons who cannot read consent forms (eg. illiterate, foreigners, etc.)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
85 Years
Study:
NCT04996303
Study Brief:
Protocol Section:
NCT04996303